Views & Analysis Artificial Intelligence for better antibody drugs: ready for... The potential of monoclonal antibodies (mAbs) as therapies is indisputable. The current mAbs market is expected to be around ~USD 150 billion.
News Pushback rises against RFK Jr's new ACIP membership Medical groups have criticised Robert F Kennedy Jr's newly constituted CDC vaccine advisory panel, calling for the previous experts to be reinstated.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face